Section 1860D-14B(f) of the Act, codified at 428.403(a)(1), precludes administrative or judicial review of the determination of units as set forth at 428.203, the determination of whether a drug is a Part D rebatable drug as set forth at 428.101, and the calculation of the rebate amount as set forth at 428.201(a) inclusive of any reconciled rebate amount
BPC-157 is not listed as a scheduled controlled substance under the international drug-control conventions or under the major national scheduling systems
In contrast, under section 1860D-14B(a) of the Act, CMS must report rebate amounts to each manufacturer of a Part D rebatable drug no later than 9 months after the end of each applicable period, except that for the first two applicable periods (that is, October 1, 2022, to September 30, 2023, and October 1, 2023, to September 30, 2024), CMS has until December 31, 2025, to invoice manufacturers for Part D inflation rebates
03 Wrong BAC water volume Adding too much or too little BAC water changes concentration and your daily draw volume